4 employees
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA.
2018
Ravel Biotechnology raised undisclosed on January 1, 2020
Investors: Hemi Ventures
Ravel Biotechnology raised undisclosed on August 23, 2019
Investors: rocketship.vc